Brian A. Fallon, MD, MPH, Professor of Clinical Psychiatry at the Columbia University College of Physicians and Surgeons, is the Director of the Lyme and Tick-borne Diseases Research Center at the Columbia University Medical Center. A graduate of Harvard College, he obtained his M.D. degree from the Columbia University College of Physicians and Surgeons, as well as a master's degree in public health epidemiology from Columbia University. He did his research training and an NIH fellowship in biological psychiatry at Columbia Presbyterian Medical Center and the New York State Psychiatric Institute. Dr. Fallon’s research has focused on neuropsychiatry – the discipline that studies the behavioral and mood effects of diseases that affect the brain. His particular areas of research focus in Lyme disease include phenomenology, diagnostics, neuroimaging, biomarker, and treatment studies. His expertise in psychiatry includes neurocognitive testing, clinical trial development, obsessive compulsive disorder, and hypochondriasis. Dr. Fallon has published over 100 peer-reviewed articles, review papers, and book chapters and he has served as a reviewer for many journals, including JAMA, Journal of Infectious Disease, Clinical Infectious Disease, and the American Journal of Psychiatry.
Kathy M. Corbera, MD is Associate Director of the Lyme and Tick-Borne Diseases Evaluation Service at the Columbia University Medical Center. She served as coordinator of the Columbia University, NIH-funded study, “PET and MRI Imaging of Persistent Lyme Encephalopathy.” Dr. Corbera has broad expertise in clinical infectious disease practice and research. She was a Research Fellow in the Department of Neurology at the Memorial Sloan-Kettering Cancer Center, and has worked abroad in clinical infectious disease and AIDS in Mexico, France and Argentina. In addition to her work at the Lyme Evaluation Service, Dr. Corbera is Associate Director of Education. She coordinates the educational fellowships sponsored by the Lyme and Tick-Borne Diseases Research Center.
John G. Keilp, PhD is an Associate Research Scientist in the Division of Neuroscience at Columbia University. He has extensive experience in the assessment of cognitive impairment in psychiatric (depression) and neurologic (dementia, HIV and Lyme encephalopathy) disorders. He has also conducted numerous studies examining correlations between cognitive deficits and brain blood flow. Dr. Keilp is widely published in peer-reviewed journals.
James R. Moeller, PhD is Assistant Professor in the Division of Geriatrics at Columbia University. He has pioneered the development of novel analytic methods for functional brain imaging data. He has published and lectured widely on these methods, which have been applied to a variety of brain disorders including Parkinsons Disease, Torsion dystonia, Alzheimer’s Disease, and Lyme Disease.
Carolyn Britton, MD, Clinical Professor of Neurology at Columbia University is the chief neurologist for our Lyme research studies. With specific expertise in neurovirology, Dr. Britton has a particular interest in the clinical care and research of patients with Lyme disease, Multiple Sclerosis, and HIV. In 2008, Dr. Britton was elected President of the National Medical Association.
Marina Makous, MD, Post-Doctoral Research Fellow in the Departments of Psychiatry and Family Medicine at Columbia University. Dr. Makous is a Board Certified Family Medicine Physician with extensive experience in Psychiatry and Mental Health Counseling. Her interests include the effect of past trauma on mental and physical health, post-treatment Lyme symptoms, Neurocognitive testing, and Psychopharmacology. She spent 10 years abroad, treating patients in West Africa, Central Asia, and the Middle East. Dr. Makous is a Clinical Instructor at the Family Medicine Residency Program at Columbia University. In addition to seeing patients at the Lyme and TIck-Borne Diseases Evaluation Service, she is conducting several research studies related to Lyme disease.
Ted Dwyer, MD, has been the primary clinical rheumatologist for our Lyme studies and has published on the role of HLA markers in Lyme arthritis.
| Top |